Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does UNSPECIFIED INGREDIENT Cause Therapy non-responder? 80 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 80 reports of Therapy non-responder have been filed in association with UNSPECIFIED INGREDIENT. This represents 0.3% of all adverse event reports for UNSPECIFIED INGREDIENT.

80
Reports of Therapy non-responder with UNSPECIFIED INGREDIENT
0.3%
of all UNSPECIFIED INGREDIENT reports
26
Deaths
31
Hospitalizations

How Dangerous Is Therapy non-responder From UNSPECIFIED INGREDIENT?

Of the 80 reports, 26 (32.5%) resulted in death, 31 (38.8%) required hospitalization, and 24 (30.0%) were considered life-threatening.

Is Therapy non-responder Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for UNSPECIFIED INGREDIENT. However, 80 reports have been filed with the FAERS database.

What Other Side Effects Does UNSPECIFIED INGREDIENT Cause?

Death (2,090) Off label use (1,306) Drug ineffective (1,227) Completed suicide (1,190) Nausea (1,041) Fatigue (1,020) Dyspnoea (934) Pneumonia (903) Asthenia (894) Vomiting (877)

What Other Drugs Cause Therapy non-responder?

ETANERCEPT (3,472) APREMILAST (3,360) METHOTREXATE (2,965) RITUXIMAB (2,731) ADALIMUMAB (2,595) PREDNISONE (2,563) TREPROSTINIL (2,289) INFLIXIMAB (2,122) TOCILIZUMAB (1,775) HYDROXYCHLOROQUINE (1,699)

Which UNSPECIFIED INGREDIENT Alternatives Have Lower Therapy non-responder Risk?

UNSPECIFIED INGREDIENT vs UPADACITINIB UNSPECIFIED INGREDIENT vs URAPIDIL UNSPECIFIED INGREDIENT vs UREA UNSPECIFIED INGREDIENT vs URIDINE TRIACETATE UNSPECIFIED INGREDIENT vs UROFOLLITROPIN

Related Pages

UNSPECIFIED INGREDIENT Full Profile All Therapy non-responder Reports All Drugs Causing Therapy non-responder UNSPECIFIED INGREDIENT Demographics